Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Bitler

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Molecular Carcinogenesis|July 26, 2023
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinomaBenjamin G Bitler, Courtney A Bailey, Tomomi M Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Intracellular MUC1 peptides inhibit cancer progressionBenjamin G Bitler, Ina Menzl, Carmen L Huerta, et al.
Molecular Diagnosis & Therapy|November 18, 2024
Leveraging Multi-omics to Disentangle the Complexity of Ovarian CancerShijuan Lin, Lily L Nguyen, Alexandra McMellen, et al.
Molecular & Cellular Proteomics : MCP|September 23, 2016
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional LevelAaron R Goldman, Benjamin G Bitler, Zachary Schug, et al.
Gynecologic Oncology Reports|April 25, 2025
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaireEric D Helm, Cam Nguyen, Stephen Rotholz, et al.
Molecular Carcinogenesis|May 26, 2021
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancerMarisa R Moroney, Elizabeth Woodruff, Lubna Qamar, et al.
Molecular Cancer Research : MCR|October 7, 2021
The Spatial Context of Tumor-Infiltrating Immune Cells Associates with Improved Ovarian Cancer SurvivalBenjamin Steinhart, Kimberly R Jordan, Jaidev Bapat, et al.
Molecular Cancer Research : MCR|January 5, 2019
Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to PaclitaxelChristopher Breed, Douglas A Hicks, Patricia G Webb, et al.
Molecular Cancer Therapeutics|May 19, 2022
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian CarcinomaBrooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, et al.
Obstetrics and Gynecology|January 4, 2024
Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic ReviewAshley Greenwood, Elizabeth R Woodruff, Cam Nguyen, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Molecular Carcinogenesis|July 26, 2023
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinomaBenjamin G Bitler, Courtney A Bailey, Tomomi M Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Intracellular MUC1 peptides inhibit cancer progressionBenjamin G Bitler, Ina Menzl, Carmen L Huerta, et al.
Molecular Diagnosis & Therapy|November 18, 2024
Leveraging Multi-omics to Disentangle the Complexity of Ovarian CancerShijuan Lin, Lily L Nguyen, Alexandra McMellen, et al.
Molecular & Cellular Proteomics : MCP|September 23, 2016
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional LevelAaron R Goldman, Benjamin G Bitler, Zachary Schug, et al.
Gynecologic Oncology Reports|April 25, 2025
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaireEric D Helm, Cam Nguyen, Stephen Rotholz, et al.
Molecular Carcinogenesis|May 26, 2021
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancerMarisa R Moroney, Elizabeth Woodruff, Lubna Qamar, et al.
Molecular Cancer Research : MCR|October 7, 2021
The Spatial Context of Tumor-Infiltrating Immune Cells Associates with Improved Ovarian Cancer SurvivalBenjamin Steinhart, Kimberly R Jordan, Jaidev Bapat, et al.
Molecular Cancer Research : MCR|January 5, 2019
Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to PaclitaxelChristopher Breed, Douglas A Hicks, Patricia G Webb, et al.
Molecular Cancer Therapeutics|May 19, 2022
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian CarcinomaBrooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, et al.
Obstetrics and Gynecology|January 4, 2024
Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic ReviewAshley Greenwood, Elizabeth R Woodruff, Cam Nguyen, et al.
Pageof 12